We’re in the News: Stay informed of Noble in the news as we advance our mission to create advanced drug delivery system trainers for the world’s leading pharmaceutical companies, which, in the end, benefit millions of patients worldwide.
Training Diabetes Patients on Self-Injection Is Essential
Ensuring that diabetes patients correctly administer their insulin or glucagon is a priority for prescribers and patients alike. Keeping tabs on the extent to which patients are (or are not) taking their medications as [...]
Training Devices Increase Patient Engagement and Adherence – Creating Better Outcomes
Across the US, half of all adults live with a chronic disease – and many of them are prescribed a self-injectable therapy to help manage their condition. As the patient population and demand for [...]
Noble Continues To Elevate Patient Access With Launch of its Innovative YpsoMate® Training Device Platform
ORLANDO – May 1, 2019 – Noble, the global leader in medical device training solutions, patient onboarding strategies and multisensory product development for the world’s top pharmaceutical brands, unveiled today a new injection training [...]
Best Practices and Considerations in Developing Effecting Training Devices for the Pulmonary Healthcare Market
Over the years, many industry stakeholders and pharmaceutical manufacturers have come to realize the importance of patient training and the role it has on promoting healthy outcomes and effective disease management. Read full article [...]
New Training Option Helps Patients Who Self-Inject
Joe Reynolds, the research manager for a company in Orlando called Noble, rolled out a new line of autoinjector training devices for families like the Jacksons. The goal is to provide a better experience [...]
For Patients Who Self-Inject, Training Devices May Hold Multiple Benefits
For patients living with Rheumatoid Arthritis, Crohn’s or other autoimmune diseases, one of the hardest parts of dealing with the condition may be the need to self-inject medication. While doctors and nurses try to [...]